Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Manufacturing Tech Groups Call for Uniform Regulations in Trans-Atlantic Pact

By Pharmaceutical Processing | November 18, 2015

Manufacturing groups on each side of the Atlantic believe that a proposed trade agreement between the U.S. and European Union should nullify duplicative regulatory standards.

The Association for Manufacturing Technology (AMT) and CECIMO—the machine tool associations of the U.S. and EU, respectively—issued a statement earlier this month arguing that ongoing negotiations over the Transatlantic Trade and Investment Partnership should enable mutual recognition of international standards for machine tool technical requirements.

The groups said that the current system maintains different standards, assessments and licensing procedures that require substantial investment of companies’ time and resources.

The distinctions, the groups added, often simply amounted to different legal methods to address the same public policy goals.

Read more: Achieving growth through globalization.

The groups also said that the trade pact should increase transparency in the regulatory process and bolster engagement with the private sector.

“The highly innovative machine tool sector stresses the need to tackle wider area than only abolishing of tariffs to provide concrete and measurable reductions to trade barriers,” the groups said.

AMT and CECIMO also called for measures that would improve small and medium-sized businesses’ access to information and markets; they noted that those companies comprise the vast majority of businesses and workers in both regions.

U.S. and EU negotiators are currently engaged in talks over the TTIP in hopes of hammering out a deal next year.

Free trade proponents—including business groups such as the AMT and CECIMO—believe such agreements open vital new export markets and ultimately promote additional domestic growth.

Critics, however, decried the secretive nature of negotiations and the deal’s potential impacts on workers and consumers.

The talks with Europe follows tense negotiations over a similar pact between the U.S. and 11 other Pacific Rim nations, including Canada, Japan, Australia, Singapore and Vietnam.

The Republican-led Congress in June granted the Obama administration authority to negotiate trade deals without the threat of subsequent amendments by lawmakers, but the measure overcame fierce opposition from many skeptical lawmakers.

A final Trans-Pacific Partnership and an eventual European pact could face similar obstacles when they reach Congress.

Related Articles Read More >

From automation islands to connected plants: A roadmap for pharma manufacturers
This is the logo of Johnson & Johnson.
Johnson & Johnson announces new North Carolina pharma plant
Myths about conveyors and measures to make data-driven purchasing decisions
The blueprint for personalized biopharma
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE